# Clinical Prospective ranDomized Trial to Evaluate the Non-inferiority of Left Bundle Branch Area Pacing Vs Cardiac ResynchronIzatioN Therapy With ECG guIded AV Optimization

Study · id `cardio:ct-nct07107048` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07107048](<https://clinicaltrials.gov/study/NCT07107048>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07107048

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 194 participants.

## Technical summary

Registry record NCT07107048. Randomized; no masking; primary purpose treatment. Start 2025-10-30 (anticipated); primary completion 2027-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 194 participants (planned count; ClinicalTrials.gov record NCT07107048, source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)
- Planned start: 2025-10-30 (anticipated) (ClinicalTrials.gov record NCT07107048, source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)
- Primary completion: 2027-04-30 (anticipated) (ClinicalTrials.gov record NCT07107048, source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)
- Completion: 2027-10-30 (anticipated) (ClinicalTrials.gov record NCT07107048, source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT07107048, source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07107048-2025-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Prospective ranDomized Trial to Evaluate the Non-inferiority of Left Bundle Branch Area Pacing Vs Cardiac ResynchronIzatioN Therapy With ECG guIded AV Optimization
- Acronym: DA VINCI
- Condition: Heart Failure
- Intervention (Device): Pacemaker and defibrillator
- Lead sponsor: Leonardo Calò, MD
- Lead sponsor class: OTHER
- Collaborator: National association Cardiovascular innovation
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: fc73cb031445b26fa341d5d1066ac6d1140220b2fedbcb9185123902e4619a80
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
